ClinicalTrials.Veeva

Menu

SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion (Drug Disposal)

S

SafeMedWaste

Status and phase

Not yet enrolling
Phase 1

Conditions

Opioid Use Disorder

Treatments

Device: SafeMedWaste

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06215170
1R43DA057750-01A1 (U.S. NIH Grant/Contract)
SafeMedWasteCT2023

Details and patient eligibility

About

There is an urgent unmet medical need for a cost-effective, environmentally friendly, in-home opioid disposal solution for surgical patients that is clinically proven to reduce opioid use disorder that is substantiated with economic data. SafeMedWaste, Inc. (SMW) has developed the patented SafeMedWaste in-home drug disposal container, that completely destroys opioids within minutes and can be placed in the regular trash, without risk of ground or municipal water contamination.

A pilot randomized clinical trial will evaluate the use of SafeMedWaste in 300 adult patients in outpatient surgery clinics undergoing shoulder and knee surgery.

Full description

The trial will evaluate opioid disposal rates and events related to opioid diversion and use disorder in 300 adult patients 18 years of age and older undergoing outpatient knee and shoulder surgery who are prescribed opioids to manage their acute post-surgical pain.

Patients will be randomized into two arms. During the standard of care post op visits (2-, 6- and 10- weeks), when the treating physician has determined that the patient will no longer need opioids to manage their post-surgical pain, all patients will receive general instructions by video on opioid disposal recorded by one of the orthopedic surgeons. Patients in the treatment arm will also be given the SafeMedWaste opioid disposal system and watch an instructional video on how to use the product.

All patients will complete a pre-surgery survey and a post-surgery survey 90 days after surgery. Patients will self-report their disposal or non-disposal of the drugs, documented with pictures uploaded to the patient's MyChart account. Data from the surveys will be statistically analyzed to identify significant factors that influenced patients' behavior vis-à-vis opioid disposal.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inclusion Criteria:

    • Subject is 18 + years of age
    • Subject is opioid naive (within the last 3 months), as evidenced by MyChart patient record or response to medical history questions
    • Subject is scheduled to undergo shoulder and/or knee surgery

Exclusion criteria

  • Subject has a history of opioid addiction, as evidenced by MyChart patient record or response to medical history questions
  • Subject is currently utilizing prescription narcotics for any reason, as evidenced by MyChart patient record or response to medical history questions
  • Subject does not have the mental capacity to make their own healthcare decisions
  • Subject is unable to provide written consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 2 patient groups

Control
No Intervention group
Description:
General Instructions on Opioid Disposal
Treatment
Active Comparator group
Description:
General Instructions on opioid disposal Device: SafeMedWaste Opioid Disposal Kit
Treatment:
Device: SafeMedWaste

Trial contacts and locations

0

Loading...

Central trial contact

Paisley T Myers, PhD Bioanalytical chemistry; Justin Stas, B.S Biomedical Engineering

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems